CLEANING VALIDATION PROBLEMS GLOBAL PERSPECTIVE

Size: px
Start display at page:

Download "CLEANING VALIDATION PROBLEMS GLOBAL PERSPECTIVE"

Transcription

1 CLEANING VALIDATION PROBLEMS GLOBAL PERSPECTIVE Paul L. Pluta, PhD Journal of Validation Technology and Journal of GXP Compliance University of Illinois at Chicago (UIC) College of Pharmacy Chicago, IL, USA 1

2 OUTLINE OVERVIEW OF IDENTIFIED PROBLEMS PRODUCT PROBLEMS Residue chemistry as basis for cleaning Solubility in worst-case residue determination Cleanability in worst case residue determination EQUIPMENT-RELATED PROBLEMS Non-uniform contamination transfer Most difficult-to-clean locations CLEANING PROCESS PROBLEMS Manual cleaning qualification Cleaning procedure documentation Dirty hold time (time to initiate cleaning) LABORATORY PROBLEMS Residue stability in cleaning residue analysis Residue recovery studies Swab sampling technique, reliability, and training 2

3 OVERVIEW CLEANING VALDIATION PROBLEMS Problems or deficiencies identified by questions and discussions with cleaning professionals at domestic and international pharma cleaning meetings. Confirmation by multiple experts Four groupings of problems / deficiencies identified Product residue problems Equipment problems Cleaning process problems Laboratory problems 3

4 AUDIT QUESTIONS Is residue chemistry considered in developing cleaning procedure? Is ph-solubility profile considered in worst-case matrix analysis? Is residue cleanability considered in worst-case residue determination? Is non-uniform contamination considered in residue calculations? Are most difficult-to-cleanto clean equipment locations proceduralized? Are manual cleaning personnel qualified and requalified? Are cleaning procedures quantitative and documented? Are dirty hold times controlled? Is residue stability considered in cleaning residue analytical? Have analytical recovery studies been conducted? On representative materials? Are swab sampling personnel trained / qualified? 4

5 LIFECYCLE APPROACH TO CLEANING VALIDATION FDA identified three stages of process validation 1. Process design and development (understanding) 2. Process qualification (performance) 3. Continued process verification (maintenance) Problems discussed indicate most cleaning deficiencies in Stage 1 process understanding, i.e., pre-work for traditional validation. Three problems are identified for Stage 2 processing. Problems in Stage 3 validation not identified. Almost no companies have a stage 3 program other than change control. 5

6 LIFECYCLE APPROACH TO PROCESS VALDIATION KEY CONCEPTS Stage approach Design and development General approaches Specific cleaning methods Process demonstration Continued process verification Scientific and technical basis Risk Variation identification and control 6

7 1. PRODUCT RESIDUE PROBLEMS Physical and chemical properties of residue as a basis for cleaning Residue chemistry, cleaning agent chemistry, and process must be consistent. Would you clean an acid with a base or with another acid? Residue solubility in most-difficult-to-clean matrix Determination of the true worst-case residue is critical for the cleaning matrix. The consequences of incorrect identification of worst-case products are disastrous. Cleanability in determining the most-difficult-to-clean residue Solubility and toxicity not only considerations for determination of worst-case compounds 7

8 PHYSICAL AND CHEMICAL PROPERTIES OF RESIDUE AS BASIS FOR CLEANING PROBLEM: No basis for cleaning procedure Arbitrarily chosen Best method at site Methods used for years for all products Bought soap at local store sale price 8

9 PHYSICAL AND CHEMICAL PROPERTIES OF RESIDUE BASIS FOR CLEANING PROCEDURE Case study #1: Antibiotic suspension containing insoluble API (base) Original cleaning method: Water, PurW, dry No documented cleaning validation for many years Unknown peaks on original cleaning validation attempts API insoluble Second method: Alkaline soap wash, water, PurW, dry Unknown peaks again API insoluble Final method: Acid wash, alkaline soap wash, water, PurW, dry Significant improvement No residues. Unknown peaks determined to be flavors. API dissolves (acid-base neutralization) Consider active drug and other residue chemistry in development of 9 cleaning process

10 CLEANING METHOD 1. Three lots with new cleaning procedure Acid cleaning liquid, drain Significant improvement in process Alkaline cleaning liquid, drain Water rinse Purified water rinse Dry 2. Swab sampling in worst case locations 3. No detectable residue, no unknown peaks 4. Unknown peaks from past trials determined to be formulation flavors (hydrophobic oils) 5. Documentation 10

11 PHYSICAL AND CHEMICAL PROPERTIES OF RESIDUE BASIS FOR CLEANING PROCEDURE Case study #2: Small molecule l API oral liquid id product. API insoluble Original cleaning method Alkaline cleaning agent with manual intervention Acid cleaning agent (full strength) when white residue noted. Small parts soaked in acid cleaning agent (full strength) Cleaning method difficult, ineffective, and unsafe Liquid product alcohol / glycol solvent system Change cleaning method to alcohol initial rinse. API soluble Final method: Alcohol rinse/soak, alkaline wash, water, PurW, dry Significant improvement No residues Easy and safe method Consider active drug and other residue chemistry in development of cleaning process 11

12 EXPERIMENTAL DEVELOPMENT PROCEDURE 1. Evaluate formulation and chemical properties 2. Laboratory comparison 2 L beaker and mixer Small amount of product into beaker + water to disperse Add cleaning agents to be screened acid, neutral, alkaline, solvent Visual observation 3. Coupons with residue in beaker 4. Simulated cleaning procedure. Swab sampling Analytical determination 5. Conclusions and recommendations 6. Confirmation in pilot equipment 12

13 CLEANING PROCEDURE DEVELOPMENT PROCESS Stage 1 R&D 1. API technical analysis. 2. ph solubility profile ph Solubility in proposed cleaning liquid. 4. ph-stability profile ph Laboratory cleaning studies confirmation. 6. Analytical method development based on stability data. 7. Testing of all excipients with analytical method. Source of unknown peaks CLEANING PROCEDURE TECHNICAL BASIS ph-solubility AND Ph-STABILITY IS BASIC R&D WORK ANALYTICAL METHOD MEASURES ACTUAL RESIDUE ANALYTICAL METHOD DETECT OTHER EXCIPIENTS 13

14 BIOTECH CLEANING CHEMISTRY -- API Protein molecules degrade in alkaline conditions Degradation rate is milder in acidic conditions Degradation rate increases with temperature API residues typically consist of protein fragments and aggregates Analytical method: Non-specific analysis Reference: Kendrick, Canhuto, and Kreuze. Analysis of Degradation Products of Biopharmaceutical API Caused by Cleaning Agents and Temperature. Journal of Validation Technology, V15, #3, Summer

15 BIOTECH CLEANING CHEMISTRY GROWTH MEDIUM Medium Composition Acids or bases Monovalent salts Polyvalent salts Amino acids Proteins (polypeptides) Carbohydrates Aqueous soluble organics Non-aqueous soluble organics Consider medium composition at end of cycle. Reference: Azadan and Canhoto. A Scientific Approach to the Selection of Cleaning Validation Worst-Case Soils for Biopharmaceutical manufacturing. Cleaning and Cleaning Validation, Volume

16 CLEANING AGENT OPTIONS Water Commodity alkalis and acids Organic solvents Surfactants Anionic Cationic Amphoteric Nonionic Formulated detergents 16

17 COMPONENTS OF FORMULATED DETERGENTS Surfactants Alkalis Acids Sequestrants / chelants Dispersants / anti-redeposition agents Corrosion inhibitors Oxidizing agents Enzymes Buffers / builders Preservatives 17

18 RESIDUE SOLUBILITY IN MOST DIFFICULT TO CLEAN MATRIX BASIS FOR CLEANING PROGRAM PROBLEM: Wrong basis for worst-case residue Water solubility USP Tables Is this adequate? Depends on cleaning procedure ph effect API with ionizable groups? Solubility in cleaning agent? Determine solubility at range ph 1-12 Understand solubility at ph of cleaning liquid Understand solubility in cleaning agent liquid 18

19 ph SOLUBILITY PROFILE, ph 1-12 Solubility mg/ml Drug A Drug B ph

20 Amount Dissolved SULFAMETHOXAZOLE ph-solubility Note pka 1 ph 12 20

21 CLEANING MATRIX Determine Worst-Case Soil SOLUBILITY (mg / ml) ph H1 Water ph H12 Alkaline li Cleaning Agent Drug A Drug B Drug C Drug D Drug E Consider acid cleaning agent for drugs D and E 21

22 CLEANABILITY IN DETERMINING MOST DIFFICULT-TO-CLEAN TO CLEAN RESIDUE IN MATRIX PROBLEM: Incomplete evaluation of worst-case residue What factors should be considered to determine worst case residue? Most companies use Solubility (ph?) Toxicity OK for site with simple dosage forms All aqueous solution products (LVP, SVP) 22

23 CLEANABILITY IN DETERMINATING MOST DIFFICULT-TO-CLEAN TO CLEAN RESIDUE IN MATRIX Matrix = Products cleaned by same cleaning procedure Other considerations Solubility in cleaning liquid Toxicity Concentration in dosage form Cleanability Formulation components major effect Cleaning personnel input Dirty hold time Soil-surface interactions (e.g., air-liquid interface) 23

24 CLEANABILITY IN DETERMINATING MOST DIFFICULT-TO-CLEAN TO CLEAN RESIDUE IN MATRIX IR Tablet ER Tablet API API Microcrystalline cellulose Same Lactose Same --- Wax --- Cellulosic polymer Crospovidone --- Talc Same Magnesium stearate Same COMPARE EASE OF CLEANING 24

25 OTHER CONSIDERATIONS Consider flavor and color oils Dyes/lakes may be more difficult to clean than active drug Consider solubility of all components Alcohol explosivity Solvent toxicity 25

26 2. EQUIPMENT PROBLEMS Non-uniform contamination transfer Non-uniform contamination is a worst-case situation and should be addressed. Calculations are demonstrated. Most difficult-to-clean locations in equipment Sites should have an SOP with a defined procedure for identification of most-difficult to clean locations in equipment. These locations are then used in sampling for cleaning validation. 26

27 NON-UNIFORM CONTAMINATION TRANSFER PROBLEM: Non-uniform contamination not considered Cleaning Processes 1. Make product A 2. Clean 3. Make product B. Remaining Product A residue contaminates Product B Equipment categorization Uniform contamination equipment Equipment with all contamination uniformly transferred. Example: Mixing tank Non-uniform contamination equipment Example: Filling needles, compressing machine. 27

28 NON-UNIFORM CONTAMINATION 1. Make 50 L tank of lemonade. 2. Fill 2 L pitcher from tank. 3. Fill cups from pitcher 4. Clean tank and pitcher. 5. Make ice tea in 50 L tank All lemonade residue in tank uniformly transferred to ice tea. 6. Fill 2 L pitcher from tank All lemonade residue in pitcher transferred to ice tea. Fill cups. HIGHEST LEVEL OF CONTAMINATION. 7. Fill same 2 L pitcher from tank Much less lemonade residue left in pitcher transferred to ice tea. Fill cups. 8. Fill same 2 L pitcher from tank Even less lemonade residue in pitcher transferred to ice tea. Fill cups. 9. And so on.. #6, 7, 8, 9.. NON-UNIFORM CONTAMINATION #6 HIGHEST LEVEL 28

29 UNIFORM CONTAMINATION CALCULATION Typical calculation considers total surface area of all shared product contact equipment, and assumes all lot A residue from total t surface area transferred uniformly to all lot B product Residue limit it = Min dose A x Batch size B x Safety factor Max dose B x Surface area References: Fourman and Mullen. Pharmaceutical Technology 17, #4, LeBlanc. Validated Cleaning Technologies for Pharmaceutical Manufacturing. Interpharm/CRC Press,

30 Product A = X Product B = X EQUIPMENT TO BE CLEANED SAMPLING LOCATIONS UNIFORM AND NON-UNIFORM CONTAMINATION Product B flushes filling lines with A residue xxxxxxxxxx x x x x x x x xxxxxxxxxx x xxxxxxxxxx x xxxxxxxxxx x x x x x x x MANUFACTURING TANK 30 PRODUCT

31 NON-UNIFORM CONTAMINATION CALCULATION Residue non-uniformly flushed into initial product units Residue content = Residue level x surface area 5ml Determine how many 5 ml vials to be discarded to be < limit. Reference: LeBlanc. Validated d Cleaning Technologies for Pharmaceutical Manufacturing. Interpharm/CRC Press,

32 NON-UNIFORM CONTAMINATION Contaminated product may be eliminated in set-up. Sites must be prepared to answer questions from auditors based on calculations. 32

33 MOST-DIFFICULT-TO-CLEAN EQUIPMENT LOCATIONS PROBLEM: No rationale for sampling of cleaned equipment. Sampling locations chosen arbitrarily. Easiest-to-clean locations chosen 33

34 MOST DIFFICULT TO CLEAN EQUIPMENT LOCATIONS Equipment Technical Evaluation Deadlegs Corners Undersides Pipe bends Flow velocity Coverage studies Drainability Other considerations (e.g., baseline visual inspection) 34

35 PROCEDURE TO DETERMINE SAMPLING LOCATIONS Specific documented procedure recommended Equipment technical evaluation Observation of equipment after processing Equipment disassembly review Cleaning procedure review Equipment evaluation review Operator interviews SOP describing above Documentation of above for equipment sampling 35

36 SAMPLING PAGES DIGITAL PICTURES One sampling page for each equipment Assemble pages for process train All pages in cleaning validation protocol Arrows for specific sampling locations Random locations unspecified Use for all cleaning validation 36

37 EQUIPMENT SAMPLING INSTRUCTIONS FOR CLEANING VALIDATION EQUIPMENT: IMPACT MILL EQUIPMENT SAMPLING LOCATION PRODUCT CONTACT MATERIAL 1. Rotor Stainless Steel Swab 2. Screen Stainless Steel Swab 3. Discharge Chute Stainless Steel Swab SAMPLE TYPE RATIONALE Maximum residue accumulation. Maximum product contact Maximum residue accumulation. Maximum product contact Maximum residue accumulation Maximum product contact X SAMPLED EQUIPMENT ASSET# EQUIPMENT NAME LOCATION Equipment #XXX Impact Mill Room XXX Equipment #XXX Impact Mill Room XXX Equipment #XXX Impact Mill Room XXX Pictures are representative of all impact mills. SAMPLED BY: DATE: VERIFIED BY: DATE: 37

38 3. CLEANING PROCESS PROBLEMS Manual cleaning qualification Manual cleaning is an inherently high risk activity. Cleaning procedure documentation Cleaning procedure documentation should be equivalent to manufacturing process documentation -- Exact requirements with personnel accountability. Dirty hold time (time to initiate cleaning) At lease one run at worst-case DHT Worst-case DHT is not always longest DHT Campaign length Max number of lots must be controlled Between lot procedure. 38

39 MANUAL CLEANING QUALIFICATION PROBLEM: Manual cleaning process Variation sources Different persons Different motivation Different physical strength Day shift, 2 nd shift, night shift And on and on and on.. 39

40 MANUAL CLEANING Manual cleaning procedures should be monitored and maintained with increased scrutiny compared to non-manual procedures More frequent training of cleaning personnel Increased supervision Periodic (annual?) revalidation batches Manual cleaning is high risk 40

41 MANUAL CLEANING -- Do you really know what is happening? Q to operator: Why is there so much foam in the tub? A: I put in extra soap because the equipment was really dirty. Q to operator: Why is there powder on the (clean) equipment? A: No problem -- We ll get the residue when we set up. Q to operator: Why don t you follow the cleaning procedure? A: The cleaning procedure really doesn t work. Q to operator: You cleaned the gasket with pure soap this is not the procedure? A: That is the only way to get it clean. Q: So why don t you tell someone to change the procedure? A: We don t have time. 41

42 MANUAL CLEANING -- Do you really know what is happening? Q to operator: Why is there powder on the clean equipment? A: It s clean enough. Q to QA (equipment inspection person): Did you approve that the equipment is clean? A: It s clean enough. Q to management: Do you know that your equipment is not clean? A: It s clean enough. Q to management: Did you finish cleaning the equipment? We are here to swab for cleaning validation. A: We cleaned the equipment three times so that we won t have any problems. Q to validation person: Did you know that the manufacturing people always clean the equipment multiple times before it is swabbed? A: Sure, we knew. Q: Why didn t you stop this? A: These people are our friends. We have to work with these people. 42

43 CLEANING PROCEDURE DOCUMENTATION PROBLEM: Exact documentation for process reproducibility Fill volume Amount of cleaning agent = concentration Time Temperature Flow rate (impact) Verification of key steps 43

44 CLEANING PROCEDURE DOCUMENTATION (Cleaning Batch Record) SOP Fill tank half full Add half scoop of soap Scrub as needed Rinse until clean Re-scrub and re-rinse if needed CLEANING PROCEDURE RECORD Fill tank with 500 L water. Sign/date Add 20.0 kg cleaning agent. Sign/date Disassemble Part A. Steps 1,2,3,4,5 Scrub for 20 minutes. Sign/date Disassemble Part B. Steps 1,2,3,4,5 Soak Part B in cleaning liquid for 10 minutes. Sign/date Rinse Part A and Part B with 50 L water. Sign/date Rinse with 50 L Purified Water. Sign/date Dry with compressed air 44

45 CLEANING PROCEDURE DOCUMENTATION (Cleaning Batch Record) Fill tank with 500 L water. Sign/date Add 20.0 kg cleaning agent. Sign/date Disassemble Part A. Steps 1,2,3,4,5 Scrub for 20 minutes. Sign/date Disassemble Part B. Steps 1,2,3,4,5 Soak Part B in cleaning liquid for 10 minutes. Sign/date Rinse Part A and Part B with 50 L water. Sign/date Rinse with 50 L Purified Water. Sign/date Dry with compressed air KEY POINTS Exact concentration of cleaning agent liquid Signature on quantitative steps Grouping non-quantitative steps (e.g., disassembly) 45

46 DIRTY HOLD TIME TIME TO INITIATE CLEANING PROBLEM: No control of dirty hold time Residue changes Drying Chemical changes Physical changes 46

47 DIRTY HOLD TIME What is Dirty Hold Time? 1. Make Product A 2. Clean 3. Make Product B How long between end of #1 and start #2? Is residue same? Does residue change? What can happen to the residue? Hydrolysis, oxidation, photolysis, physical changes, etc. Especially important in wet processes wet residue becomes dry, hardens, cakes, changes? 47

48 LABORATORY STUDY DIRTY HOLD TIME 1. Develop simulated cleaning process Coupon in beaker with stirrer 2. Weigh coupons. Aliquot residue onto coupon surface per time schedule. Allow to air dry. Weigh coupons. 3. Example time schedule: Day Day Day Day Day Day Day 0 4. Perform simulated cleaning. Observe. Air dry. Observe. 5. Weigh dry coupons. Calculate residuals. 48

49 CAMPAIGN LENGTH How many lots in manufacturing campaign before cleaning must be done? What about cleaning between batches? Equipment should be visually clean (FDA) Between lot procedure (not cleaning procedure) 49

50 4. LABORATORY PROBLEMS Residue stability in cleaning residue analysis Analytical methods must measure actual residues that are present. Residue recovery studies Analytical methods must include recovery studies, i.e., proof that process residue may be quantitatively recovered by sampling. Without recovery studies, analysis of cleaning validation samples is questionable Swab sampling technique, reliability, and training Personnel who perform swab sampling must be qualified through training with quantitative performance requirements. Training should utilize worst-case sampling methods and worst-case sampling equipment. 50

51 ANALYTICAL METHOD DEVELOPMENT PROBLEM: Analytical method does not measure actual residues Analytical method must measure actual residue Small molecules API API degraded specific or non-specific method Biotech molecules API degraded non-specific method (e.g., TOC or amino acid) UNDERSTAND RESIDUE CHEMISTRY 51

52 RESIDUE STABILITY IN CLEANING RESIDUE ANALYSIS ACTUAL RESIDUE PRESENT MUST BE MEASURED Solubility Stability Solubility considerations Hydrophilic and hydrophobic molecules Ionization Effect of ph Effect of temperature Stability considerations Hydrolysis, oxidation, photolysis, physical changes What residue is really present? Consider chemistry of residues 52

53 RESIDUE RECOVERY STUDIES PROBLEM: Is residue able to be quantitavely recovered from surfaces? Product contact t materials High % of total surface area identify all areas to be sampled Obtain representative coupons from equipment fabricators Order coupons with new equipment Recovery should be consistent and high (e.g., >50%) Recovery factor used in calculations Multiple approaches Done in lab by lab personnel consideration for future training ANALYSIS IS MEANINGLESS WITHOUT RECOVERY STUDIES 53

54 Case study RESIDUE RECOVERY STUDIES Tablet formulation, stable API, all processing on stainless steel except compressing machine (cast iron) Stainless steel recovery = 100% Audit identified no recovery on cast iron Cast iron recovery = 0% Lab analyst spiked dye tablet with active drug. Dry 5 minutes Swab Recovery = 0% Resolution: Install stainless steel dye table. 54

55 RESIDUE RECOVERY STUDIES Caution with plastics, resins, porous materials. Obtain materials from equipment fabricators Material composition Material porousity Surface roughness Example: % Recovery Neoprene smooth 79.4% Neoprene rough 11.7% Reference: Forsyth. J. Validation Technology, Vol15, #4,

56 RECOVERY STUDIES -- CALCULATION Recovery data = 50% recovery = 0.5 recovery factor Actual residue level = analytical results Recovery factor = 25 mcg/sq. cm 0.5 =50mcg/sq mcg/sq. cm 56

57 SWAB SAMPLING TECHNIQUE, RELIABILITY, AND TRAINING PROBLEM: Swab sampling must recover product residue. Sampling personnel must be trained and qualified. Periodic retraining should be considered. 57

58 ANALYTICAL METHOD DEVELOPMENT Sampling methods Sampling (swab) critical activity Training program Trained sampling personnel Demonstrated acceptable performance Documented training and retraining Worst case compounds / procedures in training Volatile solvents Problem: Solvents evaporate quickly = false negative Worst case sampling equipment Extension poles 58

59 ANALYTICAL METHODOLOGY Case study: Swab sampling with extension pole Interface Biotech tank 59

60 SAMPLING PERSONNEL TRAINING Representative sampling sites Use of auxiliary equipment Representative of most difficult analytical methods Volatile solvents time constraints Retraining considerations Who does sampling? Personnel skills 60

61 SUMMARY Cleaning personnel identified frequent overlooked problems. Residue Equipment Process Analytical 61

62 WHICH ARE MOST IMPORTANT? Risk analysis Type (potency) of drug in facility? Multi-product facility multi use equipment? Matrix? Manual cleaning? SOP cleaning processes how detailed? Signatures? Analytical recovery? Swab sampling by trained personnel? Depending on situation, many of these could be extremely serious issues 62

63 AUDIT QUESTIONS Is residue chemistry considered in developing cleaning procedure? Is ph-solubility profile considered in worst-case matrix analysis? Is residue e cleanability considered in worst-case residue e determination? Is non-uniform contamination considered in residue calculations? Are most difficult-to-clean equipment locations proceduralized? Are manual cleaning personnel qualified and requalified? Are cleaning procedures quantitative and documented? Are dirty hold times controlled? Is residue stability considered in cleaning residue analytical? Have analytical recovery studies been conducted? On representative materials? Are swab sampling personnel trained / qualified? 63

64 FUTURE DEFICIENCY Lifecycle approach requires ongoing monitoring of processes Cleaning processes must be periodically reviewed (~2 years?) Review deviations Review non-conformities Review re-cleans Management awareness Improvement projects 64

65 REFERENCES LeBlanc, Destin A. Validated Cleaning Technologies for Pharmaceutical Manufacturing. Interpharm/CRC Press, Cleaning Validation Practical Compliance Solutions for Pharmaceutical Manufacturing. PDA and DHI Publishing, Cleaning Validation Practical Compliance Solutions for Pharmaceutical Manufacturing, Volume 2. PDA and DHI Publishing, Pluta, Paul L., editor. Cleaning and Cleaning Validation, Volume 1. Basics, Expectations, and Principles. PDA and DHI Publishing, Pluta, Paul L., editor. Cleaning and Cleaning Validation, Volume 2. Application of Basics, and Principles. PDA and DHI Publishing, Kendrick, di Canhuto, and dkreuze. Analysis of fdegradation Products of fbiopharmaceutical lapic Caused by Cleaning Agents and Temperature. Journal of Validation Technology, V15, #3, Summer Cleaning Validation Forum. Coordinated by Jennifer Carlson. Journal of GXP Compliance. New Perspectives on Cleaning: Coordinated by Rizwan Sharnez. Journal of Validation Technology. Pluta and Sharnez. Avoiding Pitfalls in Cleaning Validation. Journal of GXP Compliance, V 14, #3, Summer

66 PAUL L. PLUTA, PhD Editor-in-Chief Journal of Validation Technology Journal of GXP Compliance Advanstar Communications, Iselin, NJ, USA Adjunct Associate Professor University of Illinois at Chicago (UIC) College of Pharmacy Chicago, IL, USA Editor and Chapter Author Cleaning and Cleaning Validation, Volume 1. Basics, Expectations, and Principles, 2009 Cleaning and Cleaning Validation, Volume 2. Application of Basics and Principles, 2013 PDA and Davis Healthcare International (DHI) Publishing Contact: 66

COMPLIANCE WITH EU ANNEX 15: VALIDATION AND QUALIFICATION

COMPLIANCE WITH EU ANNEX 15: VALIDATION AND QUALIFICATION COMPLIANCE WITH EU ANNEX 15: VALIDATION AND QUALIFICATION Paul L. Pluta, PhD Journal of Validation Technology Journal of GXP Compliance University of Illinois at Chicago (UIC) College of Pharmacy, Chicago,

More information

Regulatory Aspects of Cleaning and Cleaning Validation. Larry Greenstein Quality Operations, Quality Unit, Bio-Technology General, Ltd.

Regulatory Aspects of Cleaning and Cleaning Validation. Larry Greenstein Quality Operations, Quality Unit, Bio-Technology General, Ltd. Regulatory Aspects of Cleaning and Cleaning Validation Larry Greenstein Quality Operations, Quality Unit, Bio-Technology General, Ltd. 28 June 2017 Why clean? Pharmaceutical production equipment is cleaned

More information

Systems-Based Inspections for Cleaning Validation

Systems-Based Inspections for Cleaning Validation Systems-Based Inspections for Cleaning Validation FDA DG 230 July 21, 2014 Rockville, MD Destin A. LeBlanc Cleaning Validation Technologies www.cleaningvalidation.com 1 Cleaning Definition: The process

More information

Cleaning and Cleaning Validation, Volume 1 CONTENTS Introduction xix SECTION ONE CLEANING VALIDATION BASICS AND EXPECTATIONS 1 PROCESS VALIDATION BASICS 3 Paul L. Pluta Introduction 3 Process design understanding

More information

Systems-Based Inspections for Cleaning Validation

Systems-Based Inspections for Cleaning Validation Systems-Based Inspections for Cleaning Validation FDA DG 230 July 27, 2015 Rockville, MD Destin A. LeBlanc Cleaning Validation Technologies www.cleaningvalidation.com 1 Objectives Describe and/or identify:

More information

Microbiological Cleaning Method Validation

Microbiological Cleaning Method Validation Microbiological Cleaning Method Validation The purpose of cleaning procedures should never be to reduce bioburden to an acceptable level! Fergus O Connell QA Manager Eurofins ams Laboratories www.eurofins.com

More information

On-Line Total Organic Carbon as Process Analytical Technology for Cleaning Validation Risk Management

On-Line Total Organic Carbon as Process Analytical Technology for Cleaning Validation Risk Management On-Line Total Organic Carbon as Process Analytical Technology for Cleaning Validation Risk Management Ms. Mane Jyoti Madhukar Dr. Bhusnure Omprakash G. Dr. Gholve Sachin B. Suryawanshi Ranjana N. ABSTRACT

More information

Cleaning Validation. Olivier Gautier

Cleaning Validation. Olivier Gautier Cleaning Validation Olivier Gautier Cleaning Validation -" What is it? Clean Establish a documented, effective cleaning protocol Clean using what? How often? What is clean? Validate Prove that you cleaned

More information

Journal of Atoms and Molecules

Journal of Atoms and Molecules Review article Journal of Atoms and Molecules An International Online Journal ISSN 2277 1247 CLEANING VALIDATION IN PHARMACEUTICAL INDUSTRIES Abhishek Raj Senior R&D Officer, Quest Pharmaceuticals Pvt.

More information

EFFECTIVE MANAGEMENT OF THE PROCESS VALIDATION LIFECYCLE VALIDATION MASTER PLAN DEVELOPMENT

EFFECTIVE MANAGEMENT OF THE PROCESS VALIDATION LIFECYCLE VALIDATION MASTER PLAN DEVELOPMENT EFFECTIVE MANAGEMENT OF THE PROCESS VALIDATION LIFECYCLE VALIDATION MASTER PLAN DEVELOPMENT Paul L. Pluta, PhD Journal of Validation Technology Journal of GXP Compliance University of Illinois at Chicago

More information

Cleaning Procedures. These guidelines are intended for Bulk Pharmaceutical Chemicals but almost every word applies to Drug Products

Cleaning Procedures. These guidelines are intended for Bulk Pharmaceutical Chemicals but almost every word applies to Drug Products CLEANING DEVELOPMENT Cleaning Procedures as the FDA See It These guidelines are intended for Bulk Pharmaceutical Chemicals but almost every word applies to Drug Products BPC CLEANING (& Drug Products)

More information

Systems-Based Inspections for Cleaning Validation

Systems-Based Inspections for Cleaning Validation Systems-Based Inspections for Cleaning Validation FDA DG 230 March 21, 2016 Gaithersburg, MD Destin A. LeBlanc Cleaning Validation Technologies w w w.cleaningvalidation.com 1 Objectives Describe and/or

More information

Dirty-hold time effect on the cleaning process efficiency

Dirty-hold time effect on the cleaning process efficiency Available online at www.sciencedirect.com Procedia Engineering 42 (2012 ) 431 436 20 th International Congress of Chemical and Process Engineering CHISA 2012 25 29 August 2012, Prague, Czech Republic Dirty-hold

More information

CASE STUDY Risk Assessment, Limits and Inspection Approach

CASE STUDY Risk Assessment, Limits and Inspection Approach Module #4-Risk-based Analytical and Sample Method Selection, Continued Justification and Statistics-based Qualification of Visual Inspection Detection Limits and New Detectability Scales Establishing Risk-Based

More information

Manual: 038. Cleaning and Cleaning Validation of API Plant and Equipment

Manual: 038. Cleaning and Cleaning Validation of API Plant and Equipment Title: Cleaning and Cleaning Validation of API Plant and Equipment Manual Number: 38 Prepared by: Date: Supersedes: Checked by: Date: Date Issued: Approved by: Date: Review Date: Manual: 38 Cleaning and

More information

Equipment Design Consideration for Cleaning & Cleaning Validation

Equipment Design Consideration for Cleaning & Cleaning Validation Equipment Design Consideration for Cleaning & Cleaning Validation Gamal Amer, Ph. D. Principal Premier Compliance Services, Inc. All rights reserved. Do not copy without permission. 1 Cleaning and Cleaning

More information

July 2013, Vol-4, Issue -3. Research Article

July 2013, Vol-4, Issue -3. Research Article Research Article ISSN NO:0976-6723 TECHNIQUE DEVELOPMENT OF CLEANING VALIDATION FOR CHLORDIAZEPOXIDE IP TABLETS DOSAGE FORM Anurag Chaudhary 2*, Amit Chaudhary 1 1.ShriVenkateshwara University, NH-24,

More information

How to Identify Critical Quality Attributes and Critical Process Parameters

How to Identify Critical Quality Attributes and Critical Process Parameters How to Identify Critical Quality Attributes and Critical Process Parameters Jennifer Maguire, Ph.D. Daniel Peng, Ph.D. Office of Process and Facility (OPF) OPQ/CDER/FDA FDA/PQRI 2 nd Conference North Bethesda,

More information

The Use of BPOG Generated Extractables Data for Toxicological Assessment

The Use of BPOG Generated Extractables Data for Toxicological Assessment The Use of BPOG Generated Extractables Data for Toxicological Assessment Sade Mokuolu, Ph.D Group Product Compliance Manager, WMFTG PDA Brazil 2017 Disclaimer This presentation is the copyright information

More information

Cleaning and Cleaning Validation of API Plant and Equipment

Cleaning and Cleaning Validation of API Plant and Equipment Regulatory Basis: FDA Quality Systems Regulations Reference: FDA CFR - Code of Federal Regulations Title 21 1 Purpose The purpose of this guideline is: To define the requirements for cleaning plant and

More information

Dr. Sheelpriya walde Professor Gurunanak college of pharmacy, Nagpur

Dr. Sheelpriya walde Professor Gurunanak college of pharmacy, Nagpur Dr. Sheelpriya walde Professor Gurunanak college of pharmacy, Nagpur GMP ( Adopted in 1975 ) In India Good manufacturing practices are the practices required in order to conform to guidelines recommended

More information

The Life Cycle Approach to Cleaning Validation

The Life Cycle Approach to Cleaning Validation The Life Cycle Approach to Cleaning Validation Presented by: Elizabeth Rivera Technical Services Manager August 2015 Orlando, FL OMICS Conference 1/ Agenda Background Process Design Process Qualification

More information

Residue removal in Cleanroom Environments

Residue removal in Cleanroom Environments Residue removal in Cleanroom Environments PDA Midwest Indianapolis Event 06 Oct 2016 Contamination Control Solutions 1/ BIO Beth Kroeger Technical Service Manager STERIS Life Sciences 4 years 24 years

More information

Formulation Development & CTM Manufacturing Services

Formulation Development & CTM Manufacturing Services Formulation Development & CTM Manufacturing Services VxP Pharma Purdue Research Park 5225 Exploration Drive Indianapolis, IN 46241 Tel: 317.759.2299 Fax: 317.713.2950 VxP Pharmaprovides an extensive range

More information

Overview of Cleaning Validation in Pharmaceutical Industry

Overview of Cleaning Validation in Pharmaceutical Industry Overview of Cleaning Validation in Pharmaceutical Industry 1 Pankaj P Chandra Treya, 2 Dr. D N Jhade 1 Research Scholar, SSSUTMS, Sehore 2 Research Guide, SSSUTMS, Sehore Abstract Manufacturing of Pharmaceutical

More information

Cleaning Validation Challenges in Personal Care. June 15, 2017

Cleaning Validation Challenges in Personal Care. June 15, 2017 Cleaning Validation Challenges in Personal Care June 15, 2017 1 1 Agenda Developing a Cleaning Validation Plan How to Set Acceptance Criteria Execution and Understanding at the Site Level Break Out Overcoming

More information

A Survey of Cleaning Validation General Principles and Best Practices

A Survey of Cleaning Validation General Principles and Best Practices A Survey of Cleaning Validation General Principles and Best Practices International Workshop on "Vaccine Quality Management July 10-11th 2013 Hosted by Birmex, Mexico D.F. John Cyganowski EMD Millipore

More information

Audit Validation Programs Like a Champ (When your time is limited!!) Cathelene Compton 12 October 2017

Audit Validation Programs Like a Champ (When your time is limited!!) Cathelene Compton 12 October 2017 Audit Validation Programs Like a Champ (When your time is limited!!) Cathelene Compton 12 October 2017 FDA 483 Observations 2 FDA 483 Observations 3 FDA 483 Observations 4 Auditing Validation How to cover

More information

Approval Application Form for Sakura Bloom Tablets

Approval Application Form for Sakura Bloom Tablets Approval Application Form for Sakura Bloom Tablets Mock-up for Columns of Manufacturing Methods and Specifications & Test Methods for Drug Products (sample description) Study project for regulatory harmonization

More information

Cleaning validation of cleanrooms and preparation equipments

Cleaning validation of cleanrooms and preparation equipments Cleaning validation of cleanrooms and preparation equipments Dr Farshid SADEGHIPOUR Head of production Central Pharmacy, Geneva University Hospitals EAHP Foundation Seminar: Patient Safety; More About

More information

Designing an effective cleaning procedure for medical devices through laboratory studies

Designing an effective cleaning procedure for medical devices through laboratory studies Designing an effective cleaning procedure for medical devices through laboratory studies Elizabeth Rivera Technical Service Specialist STERIS Corporation elizabeth_rivera@steris.com October 2012 Agenda

More information

World Journal of Pharmaceutical Research SJIF Impact Factor 5.990

World Journal of Pharmaceutical Research SJIF Impact Factor 5.990 SJIF Impact Factor 5.990 Volume 4, Issue 9, 421-436. Review Article ISSN 2277 7105 CLEANING VALIDATION OF PHARMACEUTICAL DOSAGE FORMS Gupta Mamta* and Bharkatiya Meenakshi B.N. Institute of Pharmaceutical

More information

Health Products and Food Branch Inspectorate Graham Spry Building, 3 rd Floor 250 Lanark Avenue Address Locator # 2003D OTTAWA, Ontario K1A 0K9 January 4, 2008 07-128997-672 TO: ALL INTERESTED PARTIES

More information

The Basics of Alkaline In-Process Cleaning. for Metal Substrates. John Sparks Oakite Products, Inc. Berkeley Heights, New Jersey

The Basics of Alkaline In-Process Cleaning. for Metal Substrates. John Sparks Oakite Products, Inc. Berkeley Heights, New Jersey The Basics of Alkaline In-Process Cleaning for Metal Substrates John Sparks Oakite Products, Inc. Berkeley Heights, New Jersey This paper pertains mainly to alkaline cleaners, but includes solvents and

More information

Regulatory Perspective on Assuring Ingredient Quality

Regulatory Perspective on Assuring Ingredient Quality Regulatory Perspective on Assuring Ingredient Quality PQRI Conference December 15, 2009 Rockville, MD Steven M. Wolfgang, Ph.D., Acting Associate Director, Regulatory Science US Food and Drug Administration

More information

Risk Management in Drug Product Manufacturing with Emphasis on Batch Documentation/Execution

Risk Management in Drug Product Manufacturing with Emphasis on Batch Documentation/Execution Risk Management in Drug Product Manufacturing with Emphasis on Batch Documentation/Execution Manufacturing Breakout Session I Jack Pellett (Genentech) and Eleni Dokou (Vertex) What are typical lead-times

More information

Guidelines for Process Validation of Pharmaceutical Dosage Forms

Guidelines for Process Validation of Pharmaceutical Dosage Forms Guidelines for Process Validation of Pharmaceutical Dosage Forms Version 2.1 Date issued 21/02/2010 Date of implementation 21/05/2010 31 August 2010 Page 1 of 20 Guidelines for Process Validation of Pharmaceutical

More information

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer Part 1: General information Name of Manufacturer Production Block Physical address Contact address Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer. Clean Utilities in the Basement.

More information

Applying Cleaning Validation Principles in the Manufacture of Medical Devices and Diagnostics August 20, 2014 IVT San Diego

Applying Cleaning Validation Principles in the Manufacture of Medical Devices and Diagnostics August 20, 2014 IVT San Diego 1 Applying Cleaning Validation Principles in the Manufacture of Medical Devices and Diagnostics August 20, 2014 IVT San Diego Destin A. LeBlanc Cleaning Validation Technologies 2014 Destin A. LeBlanc Focus

More information

Best Practices for a Robust Cleaning Validation

Best Practices for a Robust Cleaning Validation Best Practices for a Robust Cleaning Validation Beth Kroeger Technical Services Specialist STERIS Life Sciences & Amanda Deal Senior Technical Services Associate STERIS Life Sciences 1/ Agenda Variables

More information

3. Equipment Cleaning Validation for Active Pharmaceutical Ingredients (APIs) 8. Process Validation for Active Pharmaceutical Ingredients (API)

3. Equipment Cleaning Validation for Active Pharmaceutical Ingredients (APIs) 8. Process Validation for Active Pharmaceutical Ingredients (API) Title: Good Working Practice Validation Requirements Practice Number: 06 Prepared by: Date: Supersedes: Checked by: Date: Date Issued: Approved by: Date: Review Date: Topics: 1. Biological Test Methods

More information

Validation. An Easy to Understand Guide Validating Purified Water Systems

Validation. An Easy to Understand Guide Validating Purified Water Systems Validation Overview Validation Documentation Validation Activities Validation Mistakes Validation Protocols Test Selection Common Verifications When to test Test Layout and Content Validation Protocol

More information

JM Hyde Consulting, Inc. ASEPCO Mixer Cleaning Study Report

JM Hyde Consulting, Inc. ASEPCO Mixer Cleaning Study Report JM Hyde Consulting, Inc. ASEPCO Mixer Cleaning Study Report An Evaluation of Mixer Cleanability Prepared By: Role Printed Name Signature Date Author Keith Bader Approved By: Role Printed Name Signature

More information

Balancing the time, cost and risk of drug development. Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL

Balancing the time, cost and risk of drug development. Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL Balancing the time, cost and risk of drug development Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL Communicating vessels Risk Time Cost Communicating vessels

More information

THE PROCESS VALIDATION OF TABLET CONTAINING IRBESARTAN 300MG AND HYDROCHLOROTHIAZIDE 12.5mg Zamir Hussain, Baqir Shyum Naqvi & Muhammad Iqbal Nasiri

THE PROCESS VALIDATION OF TABLET CONTAINING IRBESARTAN 300MG AND HYDROCHLOROTHIAZIDE 12.5mg Zamir Hussain, Baqir Shyum Naqvi & Muhammad Iqbal Nasiri THE PROCESS VALIDATION OF TABLET CONTAINING IRBESARTAN 300MG AND HYDROCHLOROTHIAZIDE 12.5mg Zamir Hussain, Baqir Shyum Naqvi & Muhammad Iqbal Nasiri Faculty of Pharmacy, Department of Pharmaceutics, Hamdard

More information

PTG-S4 Automated Powder Flow Analyzer

PTG-S4 Automated Powder Flow Analyzer PTG-S4 Automated Powder Flow Analyzer The automated PTG-S4 powder testing system is used to measure the flow behavior of granules and powders in compliance with the EP , USP Pharmacopoeia

More information

Inspection. Implementation of ICH Q8, Q9, Q10

Inspection. Implementation of ICH Q8, Q9, Q10 Implementation of ICH Q8, Q9, Q10 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Outline Aim of - as a key part of the regulatory

More information

Technical Report No. 49 Points to Consider for Biotechnology Cleaning Validation

Technical Report No. 49 Points to Consider for Biotechnology Cleaning Validation Technical Report No. 49 Points to Consider for Biotechnology Cleaning Validation 2010 Points to Consider for Biotechnology Cleaning Validation Task Force Task Force Authors Rose Bicksler, Johnson & Johnson,

More information

Validation of Pharmaceutical Manufacturing Process Focus: APIs.

Validation of Pharmaceutical Manufacturing Process Focus: APIs. Validation of Pharmaceutical Manufacturing Process Focus: APIs Validations: Regulatory History (US FDA) Sterilisation 1977 Aseptic processing 1979 Water Systems 1981 Non-sterile Mfg Process 1987 Revised

More information

Industry Perspective on Manufacturing in Early Development

Industry Perspective on Manufacturing in Early Development Industry Perspective on Manufacturing in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Eric Schmitt AbbVie IQ Drug Product Manufacturing Working Group August 2012 issue of Pharmaceutical

More information

Back TO Basics: Sample Collection & Handling

Back TO Basics: Sample Collection & Handling Back TO Basics: Sample Collection & Handling What is QA/QC? QA stands for Quality Assurance QC stands for Quality Control Both are very important to the integrity of the sample data. Both start at the

More information

Before formal cleaning validation programs

Before formal cleaning validation programs Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE May/June 2008, Vol. 28 No. 3 This article describes the development of a Visible Residue Limits (VRL) program in a pharmaceutical

More information

Method Validation Studies How GLP Interacts With Guidance Documents

Method Validation Studies How GLP Interacts With Guidance Documents Method Validation Studies How GLP Interacts With Guidance Documents Steven S. Kuwahara ROBERT GEORGE YOUNG/GETTY IMAGES GLP Forum addresses topics of interest associated with good laboratory practices.

More information

Daraclean Selection. Finding the right formulation MAGNAFLUX SOURCE

Daraclean Selection. Finding the right formulation MAGNAFLUX SOURCE Daraclean Selection Finding the right formulation MAGNAFLUX SOURCE - 2005 Daraclean Cleaners There are fourteen different Daraclean aqueous cleaner formulations How do you choose the right one for a specific

More information

Supplier Oversight PQRI. September Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan

Supplier Oversight PQRI. September Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan Supplier Oversight September 2014 PQRI Steven Lynn, MS, CMQ/OE Vice President Global Quality Compliance Mylan Agenda Mylan Background Setting the Stage with a Scenario Current State Thinking Supplier Qualification

More information

Documenta tion and Records

Documenta tion and Records Documenta tion and Records Page 1 of 30 Training Outcome of the Module: After completing this module, you will be able to: Recognize the importance of procedures Recognize the importance of record keeping

More information

ICH Q9 An Industry Perspective: Ensuring Quality to Patients in a Risk-Based Regulatory Environment

ICH Q9 An Industry Perspective: Ensuring Quality to Patients in a Risk-Based Regulatory Environment ICH Q9 An Industry Perspective: Ensuring Quality to Patients in a Risk-Based Regulatory Environment Thomas Schultz, Ph.D. Director, Regulatory Sciences Johnson & Johnson September 12, 2007 Presentation

More information

35 STATION DOUBLE ROTORY COMPRESSION MACHINE

35 STATION DOUBLE ROTORY COMPRESSION MACHINE Page 1 of 16 User Requirement Specifications 35 STATION DOUBLE ROTORY Equipment ID: T-35COMP 01 Page 2 of 16 Table of Contents 1.0 APPROVAL SIGNATURES 2.0 OVERVIEW 3.0 PROCESS DESCRIPTION 4.0 PRODUCTIVITY

More information

VALIDATION STRATEGIES FOR MULTI-PRODUCT FACILITIES

VALIDATION STRATEGIES FOR MULTI-PRODUCT FACILITIES VALIDATION STRATEGIES FOR MULTI-PRODUCT FACILITIES By: Justin Roose Head Validation Engineer Product Quality Assurance (Global Compliance) 1 Session Agenda 1. Instruction 2. Questions 3. Do it! Open-forum

More information

Best Practices For Cleaning Validation in the Aseptic Environment SUMMARY OF OUTLINE

Best Practices For Cleaning Validation in the Aseptic Environment SUMMARY OF OUTLINE Best Practices For Cleaning Validation in the Aseptic Environment Vivienne Yankah, PhD, CQE sanofi pasteur Ltd. Toronto, Canada SUMMARY OF OUTLINE Review Regulatory Standards for CV Designing and Developing

More information

ISPE S GUIDES AND HOW THEY APPLY TO CLEANING AND CLEANING VALIDATION

ISPE S GUIDES AND HOW THEY APPLY TO CLEANING AND CLEANING VALIDATION ISPE S GUIDES AND HOW THEY APPLY TO CLEANING AND CLEANING VALIDATION Stephanie A. Wilkins, PE ISPE NORDIC CLEANING VALIDATION CONFERENCE 20 April 2016 Objectives > ISPE s Risk-MaPP Guide and its impact

More information

2. Crystallization. A. Background

2. Crystallization. A. Background 2. Crystallization A. Background Crystallization is one of several available techniques available to purify organic compounds. Unlike other techniques, however, crystallization is specific to the purification

More information

University of Sulaimani College of Pharmacy Dept. of Pharmaceutics 5 th stage Second Semester

University of Sulaimani College of Pharmacy Dept. of Pharmaceutics 5 th stage Second Semester University of Sulaimani College of Pharmacy Dept. of Pharmaceutics 5 th stage Second Semester 2/26/2018 Industrial Pharmacy II, Dr. rer. nat. Rebaz Ali 1 Outlines Powder flow Introduction Factor affecting

More information

Presto Food DNA Extraction Kit

Presto Food DNA Extraction Kit Instruction Manual Ver. 06.28.17 For Research Use Only Presto Food DNA Extraction Kit Advantages FGD004 (4 Preparation Sample Kit) FGD100 (100 Preparation Kit) FGD300 (300 Preparation Kit) Sample: 200

More information

Water supplied by Marafiq does not meet the process requirements.

Water supplied by Marafiq does not meet the process requirements. WATER TREATMENT In Industries Water is used for: a. Drinking b. Cleaning c. Cooling d. Producing Steam e. Process requirement Why we need to treat water? For human consumption a. Water to be purified (Make

More information

A Framework and Case Study for Implementing the New Process Validation Guidance

A Framework and Case Study for Implementing the New Process Validation Guidance A Framework and Case Study for Implementing the New Process Validation Guidance Presented By Bikash Chatterjee President and Chief Technology Officer Pharmatech Associates Agenda Introduction Comparing

More information

STRATEGIES FOR CLEANING

STRATEGIES FOR CLEANING STRATEGIES FOR CLEANING AND CLEANING VALIDATION THAT MINIMIZE DOWNTIME FOR PRODUCT CHANGEOVERS JOHN HYDE HYDE ENGINEERING + CONSULTING PRESENTATION OUTLINE Importance of Cleaning Process Development at

More information

The Parenteral Drug Association

The Parenteral Drug Association C O N F E R E N C E R E P O R T Equipment Cleaning Microbial Control Issues By Destin A. LeBlanc, M.A. Cleaning Validation Technologies Validation: The Parenteral Drug Association (PDA) spring conference

More information

Application of Quality by Design (QbD) in product development. James E. Polli September 16, 2015

Application of Quality by Design (QbD) in product development. James E. Polli September 16, 2015 Application of Quality by Design (QbD) in product development James E. Polli jpolli@rx.umaryland.edu September 16, 2015 Pharmaceutical Equivalence Same active ingredient(s) Same dosage form Same route

More information

Establishing A Cleaning Method Validation Programme of Solid Dosage form of A Finished Drug Product

Establishing A Cleaning Method Validation Programme of Solid Dosage form of A Finished Drug Product Available online on www.ijpqa.com International Journal of Pharmaceutical Quality Assurance 2016; 7(2); 29-34 Research Article ISSN 0975 9506 Establishing A Cleaning Method Validation Programme of Solid

More information

Prequalification of Medicines Programme

Prequalification of Medicines Programme Prequalification of Medicines Programme SOP 408.4 Annex A WHO PUBLIC INSPECTION REPORT Finished Product Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: General

More information

"NOT FOR IMPLEMENTATION" GUIDANCE FOR INDUSTRY

NOT FOR IMPLEMENTATION GUIDANCE FOR INDUSTRY "NOT FOR IMPLEMENTATION" GUIDANCE FOR INDUSTRY Modified Release Solid Oral Dosage Forms Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls, In Vitro Dissolution Testing, and In Vivo

More information

THE MOLECULAR WEIGHT OF A SOLUTE*

THE MOLECULAR WEIGHT OF A SOLUTE* Name Per THE MOLECULAR WEIGHT OF A SOLUTE* One of the most helpful things that can be known about an element or compound is its molecular weight (molecular mass, gram molecular mass, atomic mass, or gram

More information

2. Crystallization. A. Background

2. Crystallization. A. Background 2. Crystallization A. Background Crystallization is one of several available techniques available to purify organic compounds. Unlike other techniques, however, crystallization is specific to the purification

More information

At LATITUDE, we only do one thing, and we do it very well.

At LATITUDE, we only do one thing, and we do it very well. Formulation Experts for Insoluble Compounds At LATITUDE, we only do one thing, and we do it very well. LATITUDE Pharmaceuticals Inc. has been tackling the most difficult drug formulation challenges for

More information

A Compilation of WHO GMP Audit Points

A Compilation of WHO GMP Audit Points A Compilation of WHO GMP Audit Points Collected from WHOPIR of 28 companies Part III of VIII Current article Part III Production Prepared and Submitted By: Edited by : A. Jwalakanth B.Pharm, MBA (Aus)

More information

IJPRD, 2011; Vol 4(02): April-2012 ( ) International Standard Serial Number

IJPRD, 2011; Vol 4(02): April-2012 ( ) International Standard Serial Number IJPRD, 2011; Vol 4(02): April-2012 (175-179) International Standard Serial Number 0974 9446 --------------------------------------------------------------------------------------------------------------------------------------------------

More information

Pharma Ingredients & Services. Kollicoat IR White. Technical Information

Pharma Ingredients & Services. Kollicoat IR White. Technical Information Technical Information Kollicoat IR White August 2008 Supersedes issue dated June 2008 EMP 040901e-10/Page 1 of 12 = Registered trademark of BASF SE Ready-to-use coating for instant-release dosage forms

More information

á1225ñ VALIDATION OF COMPENDIAL PROCEDURES

á1225ñ VALIDATION OF COMPENDIAL PROCEDURES 1640 á1224ñ Transfer of Analytical Procedures / General Information USP 39 THE ANALYTICAL PROCEDURE The procedure should be written with sufficient detail and explicit instructions, so that a trained analyst

More information

Application of PAT for Tablet Analysis. Case examples from Novartis Lorenz Liesum, Lead PAT Hamburg, 19 th of April 2013

Application of PAT for Tablet Analysis. Case examples from Novartis Lorenz Liesum, Lead PAT Hamburg, 19 th of April 2013 Application of PAT for Tablet Analysis Case examples from Novartis Lorenz Liesum, Lead PAT Hamburg, 19 th of April 2013 Agenda PAT@Novartis Organization Business Drivers and Cases NIR Spectroscopy for

More information

Advancements on implementation of single use technology in vaccine manufacturing

Advancements on implementation of single use technology in vaccine manufacturing Advancements on implementation of single use technology in vaccine manufacturing October 25 th, 2013 DCVMN Meeting Rio de Janeiro, Brazil Outline Overview of single use products Applications of single

More information

Compounding Pharmacies and Water

Compounding Pharmacies and Water Compounding Pharmacies and Water Scott Sutton, PhD scott.sutton@microbiol.org August 21, 2014 46 Disclaimer I am an independent consultant. I have been involved with USP for many years. I do not represent

More information

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

USP Chapter 823 USP 32 (old) vs. USP 35 (new) USP Chapter 823 USP 32 (old) vs. USP 35 (new) Sally W. Schwarz, MS, BCNP Research Associate Professor of Radiology Washington University School of Medicine St. Louis, MO Why USP Chapter ? FDA has

More information

TEMPLATE FOR AN EXAMPLE METHODS VALIDATION STANDARD OPERATING PROCEDURE (SOP)

TEMPLATE FOR AN EXAMPLE METHODS VALIDATION STANDARD OPERATING PROCEDURE (SOP) APPENDIX II TEMPLATE FOR AN EXAMPLE METHODS VALIDATION STANDARD OPERATING PROCEDURE (SOP) SOP EXAMPLE TEMPLATE 1. PURPOSE 1.1 This procedure is intended to provide general guidelines for the validation

More information

SITE MASTER FILE For MHRA

SITE MASTER FILE For MHRA ABC CO., LTD. For MHRA Prepared by Date Approved by Date Verified by Date Document No.: SMF, Version No: 01, Effective Date: 09/05/06 Document No.: SMF Version No.: 01 Effective Date: 09/05/06 Page 2 of

More information

Regulation. Code of Federal Regulations in the United States. Chapter 1 Title 21 CFR is the title for pharmaceuticals.

Regulation. Code of Federal Regulations in the United States. Chapter 1 Title 21 CFR is the title for pharmaceuticals. ASME BPE 2014 The ASME BPE standard provides requirements for systems and components that are subject to cleaning and sanitization and/or sterilization including systems that are cleaned in place (CIP)

More information

WHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products

WHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products WHO GUIDELINE Stability testing of active pharmaceutical ingredients and finished pharmaceutical products 1. Introduction 1.1 Objectives of these guidelines 1.2 Scope of these guidelines 1.3 General principles

More information

PHARMACEUTICAL MANUFACTURING

PHARMACEUTICAL MANUFACTURING PHARMACEUTICAL MANUFACTURING WHAT IS PHARMACEUTICAL MANUFACTURING IT IS THE PROCESS OF INDUSTRIAL SCALE SYNTHESIS OF PHARMACEUTICAL DRUG BY PHARMACEUTICAL COMPANIES. THE PROCESS CAN BE BROKEN DOWN INTO

More information

Maximizing Sample Recovery on the ACCQPrep HP125

Maximizing Sample Recovery on the ACCQPrep HP125 Maximizing Sample Recovery on the ACCQPrep HP125 Chromatography Technical Note TN42 Overview This technical note is to investigate the sample recovery and injection efficiency of different methods of injection

More information

Streamlined Manufacture of Modified Release Matrix Tablets via Direct Compression. Katie Hewlett, Dow Gus LaBella, Colorcon

Streamlined Manufacture of Modified Release Matrix Tablets via Direct Compression. Katie Hewlett, Dow Gus LaBella, Colorcon Streamlined Manufacture of Modified Release Matrix Tablets via Direct Compression Katie Hewlett, Dow Gus LaBella, Colorcon Controlled Release Alliance Unique Together Leading polymer expertise Quality

More information

Process Drift: When Do We Detect it? Richard L. Friedman Director, DMPQ CDER/Office of Compliance PQRI Process Drift Workshop December 1, 2010

Process Drift: When Do We Detect it? Richard L. Friedman Director, DMPQ CDER/Office of Compliance PQRI Process Drift Workshop December 1, 2010 Process Drift: When Do We Detect it? Richard L. Friedman Director, DMPQ CDER/Office of Compliance PQRI Process Drift Workshop December 1, 2010 Overview Goal of Manufacturing Central Question: Why is process

More information

American Journal of Advanced Drug Delivery.

American Journal of Advanced Drug Delivery. American Journal of Advanced Drug Delivery www.ajadd.co.uk Original Article Development and Study of an Erodible Matrix Drug Delivery Platform for Sustained Release of Non-Steroidal Anti-Inflammatory Drugs

More information

Philosophy and Validation Approach to Cleaning and Decontamination in Antibiotics Faci I i ties

Philosophy and Validation Approach to Cleaning and Decontamination in Antibiotics Faci I i ties European Journal of Parenteral Sciences 1996; l(4): 17-1 12 1996 Parenteral Society Philosophy and Validation Approach to Cleaning and Decontamination in Antibiotics Faci I i ties Wael Allan and Trevor

More information

Extractable and Leachable Challenges From a generic injectable drug development perspective

Extractable and Leachable Challenges From a generic injectable drug development perspective Extractable and Leachable Challenges From a generic injectable drug development perspective Andrea Redd Director, US Regulatory Affairs Fresenius Kabi November 8, 2017 Disclaimer This presentation contains

More information

Cleaning Validation: A Timely Solution for Improving Quality and Containing Cost

Cleaning Validation: A Timely Solution for Improving Quality and Containing Cost : A Timely Solution for Improving Quality and Containing Cost by Christopher Crone This article presents an economic case for the use of on-line Total Organic Carbon (TOC) and conductivity analysis for

More information

BIOEQUIVALENCE TRIAL INFORMATION

BIOEQUIVALENCE TRIAL INFORMATION PRESENTATION OF BIOEQUIVALENCE TRIAL INFORMATION BIOEQUIVALENCE TRIAL INFORMATION GENERAL INSTRUCTIONS: Please review all the instructions thoroughly and carefully prior to completing the Bioequivalence

More information

Cleaning Validation in a Biologics Facility Case Study. CBE Pty Ltd

Cleaning Validation in a Biologics Facility Case Study. CBE Pty Ltd Cleaning Validation in a Biologics Facility Case Study CBE Pty Ltd This training program is copyright to CBE Pty Ltd and may not be modified, reproduced, sold, loaned, hired or traded in any form without

More information

WARNING LETTER CMS #

WARNING LETTER CMS # U.S. Food and Drug Administration Division of Pharmaceutical Quality Operations I 10 Waterview Blvd 3rd FL, Parsippany NJ 07054 Telephone: (973) 331-4900 Fax: (973) 331-4969 www.fda.gov Via UPS Next Day

More information

TROUBLESHOOTING. Autosampler Carryover

TROUBLESHOOTING. Autosampler Carryover 754 LCGC NORTH AMERICA VOLUME 24 NUMBER 8 AUGUST 2006 www.chromatographyonline.com LC TROUBLESHOOTING Autosampler Carryover Why is the blank never clean? John W. Dolan LC Troubleshooting Editor Carryover

More information